Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA takes a closer look at possible cancer risks of widely used blood pressure medicines
FDA takes a closer look at possible cancer risks of widely used blood pressure medicines
FDA takes a closer look at possible cancer risks of widely used blood pressure medicines
Submitted by
admin
on July 16, 2010 - 9:26am
Source:
Star Ledger, NJ
News Tags:
FDA
cancer
ARBs
Merck
Cozaar
Bristol-Myers Squibb
Avapro
Atacand
Benicar
Diovan
Micardis
Teveten
Headline:
FDA takes a closer look at possible cancer risks of widely used blood pressure medicines
Do Not Allow Advertisers to Use My Personal information
